Funding round
Sanfer Growth
Reported as "Growth Equity"
Sanfer, which works in pharmaceutical product research and development in México, raised $500M in a Growth round announced on 19 Aug 2019, led by La Caisse. 1 firm took part.
$500M
Amount raised
Not disclosed
Post-money valuation
1
Investors
1 lead
Valuation
What this round says about the price
Sanfer did not disclose a valuation in this round. It is Sanfer's first venture round on record, 78 years after it was founded in 1941. No later venture round is on record for Sanfer.
Sanfer's funding rounds
This is the only venture round on record for Sanfer.
- Growth this round 19 Aug 2019, led by La Caisse $500M
Investors
Who put money in
La Caisse led the round.
Lead investor
- La Caisse backs 43 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, geographic expansion, sales and marketing, scaling operations, acquisitions and working capital.
- Product development
- Geographic expansion
- Sales and marketing
- Scaling operations
- Acquisitions
- Working capital
Comparable rounds
How it compares
10 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $83M, and this round was 6.0 times the median. The closest in time, other companies' Growth rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 16 Jul 2019 | $130M | $783M | EQT and Andera Partners |
| Pharmaceutical Products | 4 Sep 2019 | $66M | not disclosed | ADM Capital |
| Pharmaceutical Products | 11 Jul 2019 | $32M | not disclosed | Sofinnova Partners and Bpifrance |
| Pharmaceutical Products | 28 Jan 2020 | $200M | not disclosed | not named |
| Pharmaceutical Products | 8 Jan 2019 | $160M | not disclosed | not named |
| Pharmaceutical Products | 10 Mar 2020 | $35M | not disclosed | Bupa Australia and Federation Asset Management |
| Pharmaceutical Products | 21 Jan 2019 | $31M | not disclosed | not named |
| RemeGen Pharmaceutical Products | 2 Apr 2020 | $100M | not disclosed | Lilly Asia Ventures and Lake Bleu Capital |
Sources
Where this comes from
Reported by 3 sources.
Questions
Frequently asked
How much did Sanfer raise in its Growth round?
Sanfer raised $500M in its Growth round, announced in Aug 2019.
Who led Sanfer's Growth round?
La Caisse led it.
What was Sanfer's valuation at the Growth round?
It was not disclosed.
How does it compare with other Growth rounds in Pharmaceutical Products?
10 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $83M, and this round was 6.0 times the median.